10x Genomics shares are trading lower following worse-than-expected Q1 results.
Portfolio Pulse from Benzinga Newsdesk
10x Genomics shares are trading lower due to worse-than-expected Q1 results.

April 30, 2024 | 9:58 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
10x Genomics shares are trading lower following worse-than-expected Q1 results.
Shares of 10x Genomics are trading lower as the company reported Q1 results that did not meet expectations. This negative earnings surprise typically leads to a decrease in stock price in the short term as investors adjust their expectations.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100